Expression of Fas ligand protein in human non-small cell lung cancer and its clinical significance
- VernacularTitle:FasL蛋白在人类非小细胞肺癌中的表达及其临床意义
- Author:
Yidan LIN
;
Yaoguang JIANG
;
Ruwen WANG
- Publication Type:Journal Article
- From:Journal of Third Military Medical University
2001;23(5):530-532
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression of Fas ligan d (FasL) protein in human non-small cell lung cancer (NSCLC) and its clinic al significance. Methods Expression of FasL protein was detecte d by immunohistochemical method in 32 resected tumors of NSCLC. Results FasL protein was detected in all of these 32 resected tumors with variant pos itive expression levels ranging from 3.0% to 98.7% ［mean (62.0±32.0)%］. T here wa s significant difference between the tumors of different pathological types no s ignificant difference was found between the tumors of different differentiation nor among the tumors of different pTNM stages (P>0.05). Conclusion The results indicated that NSCLC can counterattack the immune cells of t he body and may be the molecular basis for the easily metastasis of adenocarcino ma to in the early stage.
